Literature DB >> 16279946

Induction of PAI-1 expression by tumor necrosis factor alpha in endothelial cells is mediated by its responsive element located in the 4G/5G site.

Maria Swiatkowska1, Janusz Szemraj, Czeslaw S Cierniewski.   

Abstract

Plasminogen activator inhibitor type 1 (PAI-1) is induced by many proinflammatory and pro-oxidant factors. Among them, tumor necrosis factor alpha (TNFalpha), a pivotal early mediator that regulates and amplifies the development of inflammation, is one of the strongest PAI-1 synthesis activators. Location of the TNFalpha response element in the PAI-1 promoter is still ambiguous. In this study, we attempted to evaluate the significance of the element located in the 4G/5G site of the PAI-1 promoter in the TNFalpha stimulation of PAI-1 expression in endothelial cells. PAI-1 expression was monitored at: (a) the level of mRNA using real-time PCR, (b) PAI-1 gene transcription by transfection reporter assays, and (c) protein synthesis using the enzyme immunoassay. NF-kappaB activity was monitored using the electrophoretic mobility shift assay. Its activity was modified by either antisense oligonucleotides or transfection of endothelial cells with the wild-type or mutated IkappaBalpha. We have shown that TNFalpha-induced expression and gene transcription of PAI-1 involves a regulatory region present in segment -664/-680 of the PAI-1 promoter. This reaction involves the TNFalpha-induced generation of superoxide leading to activation of NF-kappaB, and can be abolished by antioxidants and by overexpression of a super-suppressor phosphorylation-resistant IkappaBalpha. Stimulation of PAI-1 under these conditions involves the motif of the PAI-1 promoter adjacent to the 4G/5G site, which can directly interact with NF-kappaB. We show that activation of PAI-1 gene by TNFalpha and reactive oxygen species is mediated by interaction of NF-kappaB with the cis-acting element located in the -675 4G/5G insertion/deletion in the PAI-1 promoter.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16279946     DOI: 10.1111/j.1742-4658.2005.04979.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  13 in total

1.  Prognostic value of PAI1 in invasive breast cancer: evidence that tumor-specific factors are more important than genetic variation in regulating PAI1 expression.

Authors:  Mark D Sternlicht; Alison M Dunning; Dan H Moore; Paul D P Pharoah; David G Ginzinger; Koei Chin; Joe W Gray; Frederic M Waldman; Bruce A J Ponder; Zena Werb
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-11       Impact factor: 4.254

Review 2.  Oxidative stress, plasminogen activator inhibitor 1, and lung fibrosis.

Authors:  Rui-Ming Liu
Journal:  Antioxid Redox Signal       Date:  2008-02       Impact factor: 8.401

3.  Ginkgolic acids inhibit migration in breast cancer cells by inhibition of NEMO sumoylation and NF-κB activity.

Authors:  Sami Hamdoun; Thomas Efferth
Journal:  Oncotarget       Date:  2017-05-23

4.  TM5441, a plasminogen activator inhibitor-1 inhibitor, protects against high fat diet-induced non-alcoholic fatty liver disease.

Authors:  Seon Myeong Lee; Debra Dorotea; Inji Jung; Tetsuo Nakabayashi; Toshio Miyata; Hunjoo Ha
Journal:  Oncotarget       Date:  2017-09-21

Review 5.  Cell Type-Specific Roles of NF-κB Linking Inflammation and Thrombosis.

Authors:  Marion Mussbacher; Manuel Salzmann; Christine Brostjan; Bastian Hoesel; Christian Schoergenhofer; Hannes Datler; Philipp Hohensinner; José Basílio; Peter Petzelbauer; Alice Assinger; Johannes A Schmid
Journal:  Front Immunol       Date:  2019-02-04       Impact factor: 7.561

Review 6.  Cytokines as therapeutic targets for cardio- and cerebrovascular diseases.

Authors:  Luca Liberale; Stefano Ministrini; Federico Carbone; Giovanni G Camici; Fabrizio Montecucco
Journal:  Basic Res Cardiol       Date:  2021-03-26       Impact factor: 17.165

7.  PAI-1 promoter 4G/5G polymorphism (rs1799768) contributes to tumor susceptibility: Evidence from meta-analysis.

Authors:  Xin Xu; Yanqi Xie; Yiwei Lin; Xianglai Xu; Yi Zhu; Yeqing Mao; Zhenghui Hu; Jian Wu; Hong Chen; Xiangyi Zheng; Jie Qin; Liping Xie
Journal:  Exp Ther Med       Date:  2012-10-02       Impact factor: 2.447

8.  Do inflammation and procoagulation biomarkers contribute to the metabolic syndrome cluster?

Authors:  Aldi T Kraja; Michael A Province; Donna Arnett; Lynne Wagenknecht; Weihong Tang; Paul N Hopkins; Luc Djoussé; Ingrid B Borecki
Journal:  Nutr Metab (Lond)       Date:  2007-12-21       Impact factor: 4.169

Review 9.  NF-kappa B: a new player in angiostatic therapy.

Authors:  Sebastien P Tabruyn; Arjan W Griffioen
Journal:  Angiogenesis       Date:  2008-02-19       Impact factor: 9.596

Review 10.  A Serpin With a Finger in Many PAIs: PAI-1's Central Function in Thromboinflammation and Cardiovascular Disease.

Authors:  Gael B Morrow; Claire S Whyte; Nicola J Mutch
Journal:  Front Cardiovasc Med       Date:  2021-04-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.